Lung cancer screening for high-risk patients: A quality improvement initiative to improve guideline adherence in real-world primary care practices. The abstract by Patel et al, entitled ...
Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results